Abstract:Highlights • In this study, all investigation and experiments have obtained patients' consent and been approved by the Ethic Committee for Clinical Research of Shanghai Tenth People's Hospital. • Urolithin A inhibits breast cancer cell and tumor macrophage IL-6 secretion through different mechanisms. • Urolithin A suppresses tumor macrophages harmful Inflammation through activation of mitophagy. • Urolithin A-mediated mitophagy and antitumor activity depend on TFEB nuclear translocation. • C212S mutation abolishes the effect of urolithin A blocking 1433 recognition of phosphorylated TFEB. Introduction Urolithin A (UA) is a naturally occurring compound that is converted from ellagitannin-like precursors in pomegranates and nuts by intestinal flora. Previous studies have found that UA exerts tumor-suppressive effects through antitumor cell proliferation and promotion of memory T-cell expansion, but its role in tumor-associated macrophages remains unknown. Objectives Our study aims to reveal how UA affects tumor macrophages and tumor cells to inhibit breast cancer progression. Methods Observe the effect of UA treatment on breast cancer progression though in vivo and in vitro experiments. Western blot and PCR assays were performed to discover that UA affects tumor macrophage autophagy and inflammation. Co-ip and Molecular docking were used to explore specific molecular mechanisms. Results We observed that UA treatment could simultaneously inhibit harmful inflammatory factors, especially for InterleuKin-6 (IL-6) and tumor necrosis factor α (TNF-α), in both breast cancer cells and tumor-associated macrophages, thereby improving the tumor microenvironment and delaying tumor progression. Mechanistically, UA induced the key regulator of autophagy, transcription factor EB (TFEB), into the nucleus in a partially mTOR-dependent manner and inhibited the ubiquitination degradation of TFEB, which facilitated the clearance of damaged mitochondria via the mitophagy-lysosomal pathway in macrophages under tumor supernatant stress, and reduced the deleterious inflammatory factors induced by the release of nucleic acid from damaged mitochondria. Molecular docking and experimental studies suggest that UA block the recognition of TFEB by 1433 and induce TFEB nuclear localization. Notably, UA treatment demonstrated inhibitory effects on tumor progression in multiple breast cancer models. Conclusion Our study elucidated the anti-breast cancer effect of UA from the perspective of tumor-associated macrophages. Specifically, TFEB is a crucial downstream target in macrophages. Graphical abstract Download : Download high-res image (155KB) Download : Download full-size image

Taurine Inhibits Lung Metastasis in Triple-Negative Breast Cancer by Modulating Macrophage Polarization Through PTEN-PI3K/Akt/mTOR Pathway

An integrated metabonomics study to reveal the inhibitory effect and metabolism regulation of taurine on breast cancer

[Combination of Lapatinib with Chlorogenic Acid Inhibits Breast Cancer Metastasis by Suppressing Macrophage M2 Polarization].

Taurine Induces the Apoptosis of Breast Cancer Cells by Regulating Apoptosis-Related Proteins of Mitochondria

Mir-182 Targeting Reprograms Tumor-Associated Macrophages and Limits Breast Cancer Progression

Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor‐Associated Macrophages in Prostate Cancer

Β-Elemene Inhibits Tumor-Promoting Effect of M2 Macrophages in Lung Cancer.

Anemoside A3 Inhibits Macrophage M2-Like Polarization to Prevent Triple-Negative Breast Cancer Metastasis

Combined MEK Inhibition and Tumor-Associated Macrophages Depletion Suppresses Tumor Growth in a Triple-Negative Breast Cancer Mouse Model

Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment

TFEB regulates tumor-associated macrophages in breast cancer through autophagy-dependent and independent pathways

Matrine suppresses lung cancer metastasis via targeting M2-like tumour-associated-macrophages polarization

PD‑L1 Mediates Triple‑negative Breast Cancer Evolution Via the Regulation of TAM/M2 Polarization.

Honokiol Prevents Lung Metastasis of Triple-Negative Breast Cancer by Regulating Polarization and Recruitment of Macrophages.

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer

Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy

Urolithin a inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages

Taurine Antagonizes Macrophages M1 Polarization by Mitophagy-Glycolysis Switch Blockage via Dragging SAM-PP2Ac Transmethylation

Tumor-targeted Gene Therapy with Lipid Nanoparticles Inhibits Tumor-Associated Adipocytes and Remodels the Immunosuppressive Tumor Microenvironment in Triple-Negative Breast Cancer

Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy